v3.25.2
Share-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense
The following table presents share-based compensation expense and the related tax benefits for the periods indicated:
Three Months Ended March 31,
($ in thousands)20252024
Share-based compensation expense related to:
Stock options
$68 $72 
Restricted stock awards
162 64 
Total share-based compensation expense
$230 $136 
Related tax benefits
$61 $34 
The following table presents unrecognized share-based compensation expense as of the date indicated:
March 31, 2025
($ in thousands)Unrecognized ExpenseWeighted-Average Remaining Expected Recognition Period
Unrecognized share-based compensation expense related to:
Stock options
$454 1.8 years
Restricted stock awards
2,130 3.5 years
Total unrecognized share-based compensation expense
$2,584 3.2 years
Schedule of Stock Options
The following tables represent stock option activity for the periods indicated:
Three Months Ended March 31, 2025
($ in thousands except per share data)
Number of SharesWeighted-Average Exercise Price Per ShareWeighted-Average Contractual TermAggregated Intrinsic Value
Outstanding at beginning of period
576,412 $14.20 5.0 years$3,481 
Exercised
(57,201)$11.96 3.4 years
Outstanding at end of period
519,211 $14.45 4.9 years$2,213 
Exercisable at end of period
347,552 $13.75 3.2 years$1,725 
The following table represents information regarding unvested stock options for the periods indicated:
Three Months Ended March 31, 2025
Number of SharesWeighted-Average Exercise Price Per Share
Outstanding at beginning of period
179,659 $15.93 
Vested(8,000)$17.40 
Outstanding at end of period
171,659 $15.87 
Schedule of Restricted Stock Awards
The following table represents restricted stock award activity for the periods indicated:
Three Months Ended March 31, 2025
Number of SharesWeighted-Average Grant Date Fair Value Per Share
Outstanding at beginning of period
119,100 $20.40 
Vested(5,000)$21.96 
Outstanding at end of period
114,100 $20.34